Consistent with this hypothesis, Rehman et al. demonstrated that either the inhibition of Drp1 or expression of Mfn2 impairs a lung cancer cell’s ability to progress through the cell cycle and decreases tumor growth in a xenograft model [51]. The gene discussed is MFN2; the disease is lung cancer.